IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2020 earnings per share (“EPS”) of $2.01, reflecting a 93.3% year-over-year rise. The determine surpassed the Zacks Consensus Estimate by 40.6%. www.nasdaq.com
IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2020 earnings per share (“EPS”) of $2.01, reflecting a 93.3% year-over-year rise. The determine surpassed the Zacks Consensus Estimate by 40.6%.
www.nasdaq.com